Interface Biologics

Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI’s primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.
Type
Private
HQ
Toronto, CA
Founded
2001
Employees
23 (est)+5%

Interface Biologics Locations

Toronto, CA

Interface Biologics Metrics

Interface Biologics Summary

Founding Date

2001

Total Funding

$32 M

Time since last funding

almost 2 years

Investors

Interface Biologics News

Interface Biologics Company Life